Search Results
Dr. Blackwell on the Impact of the CLEOPATRA and MARIANNE Studies in HER2+ Breast Cancer
Dr. Blackwell on Treatment Landscape of HER2+ Breast Cancer
Kimberly Blackwell, MD: Considerations for Different Therapies in Breast Cancer
Kimberly Blackwell, MD: Choices of Therapy
Adjuvant Therapy for Breast Cancer
Kimberly Blackwell, MD: Considerations for Different Therapi
HER2+ MBC - Dr. Carey Anders - 2014 MBCN Conference at UNC
Duke Pioneers Gentler Breast Cancer Drugs
WeOncologists ESO Presents:"Current Landscape in HER2+ metastatic Breast Cancer” by Philippe Aftimos
Kimberly Blackwell, MD: Expectations of Therapy
Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer
Kimberly Blackwell, MD: Expectations of Therapy in Breast Cancer
